By Clinical Proteomic Tumor Analysis Consortium (CPTAC) data for protein expression only available for ADC, we confirmed that there was a significant overexpression of E-cadherin, Col I, Col III, Col V, WNT5A, and SPARC protein, while there was a significant under-expression of β-catenin, HS, CS, and Col IV. The gene discussed is SPARC; the disease is neoplasm.